Botanical species · safety record

Angelica polymorpha

The EFSA Compendium of Botanicals holds 14 constituent measurements for Angelica polymorpha. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Angelica polymorpha Maxim.

14Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Bergapten	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Columbianadin	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Imperatorin	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Isoimperatorin	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Isooxypeucedanin	—	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Isopimpinellin	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Osthol	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Phellopterin	Roots and other underground parts	Solvent extraction	—	HPLC-MS/MS	Resolve DOI
Bisabolangelone	Unspecified	—	—	Chromatographic tests	No resolvable identifier
Ligustilide	Unspecified	—	—	GC-MS	No resolvable identifier
Octanal	Unspecified	—	—	GC-MS	No resolvable identifier
Pabulenol	Unspecified	—	—	Chromatographic tests	No resolvable identifier
Saxalin	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Umbelliferone	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Dan, Feijun., Cai, Zhengjun., Lin, Shilong., Pan, Jiarong., Wang, Li. Analysis of components in volatile oil by different extraction methods of Angelica polymorpha maxim.. Jingxi huagong, 2009, vol. 26, no. 5, p. 468-471.
Liu, Na., Yu, Nengjiang J., Li, Jin., Yang, Yu., Guo, Jifen F., Zhao, Yimin M. Simultaneous Qualitative Analysis of Coumarins in the Rhizome of Angelica polymorpha Maxim. by LC-DAD-ESI-MS . Chromatographia, 2011, vol. 73, no. 11-12, p. 1121-1129. DOI
Cai, Zheng-jun., Dan, Fei-jun., Cheng, Fan., Wang, Jun-zhi., Zou, Kun. Chemical constituents of antibacterial activity fraction of Angelica polymorpha . . Zhong yao cai = zhongyaocai = journal of chinese medicinal materials, 2008, vol. 31, no. 8, p. 1160-2.
Yang, Yu., Yu, Neng-jiang., Liang, Fei-fei., Zhang, Yang., Ren, Feng-xia., Zhang, Ai-jun., Zhao, Yi-min. Studies on chemical constituents of Angelica polymorpha Maxim (II). Jiefangjun yaoxue xuebao, 2010, vol. 26, no. 3, p. 189-191.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature